Birdwatch Archive

Birdwatch Note

2022-12-13 17:17:48 UTC - NOT_MISLEADING

“Ivermectin is not approved by the FDA for treatment of any viral infection.” Covid-19 Treatment Panel recommends against use of Ivermectin to treat covid except in clinical trials. https://www.covid19treatmentguidelines.nih.gov/therapies/miscellaneous-drugs/ivermectin/ NB: article I cited herein is written in 2022 unlike older study cited by another poster.

Written by 7DAF7E766C91C4681BD9E35A65ED1244CD021FD7E551BF6AB85D6DF31D7EAC10
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1602152106219257858

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1602714417351004161
  • noteId - 1602714417351004161
  • participantId - 7DAF7E766C91C4681BD9E35A65ED1244CD021FD7E551BF6AB85D6DF31D7EAC10
  • noteAuthorParticipantId -
  • createdAtMillis - 1670951868748
  • tweetId - 1602152106219257858
  • classification - NOT_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 0
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 0
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 1
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • “Ivermectin is not approved by the FDA for treatment of any viral infection.” Covid-19 Treatment Panel recommends against use of Ivermectin to treat covid except in clinical trials. https://www.covid19treatmentguidelines.nih.gov/therapies/miscellaneous-drugs/ivermectin/ NB: article I cited herein is written in 2022 unlike older study cited by another poster.

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2022-12-13 17:17:48 UTC
(1670951868748)
1969-12-31 23:59:59 UTC
(-1)
2022-12-14 00:42:01 UTC
(1670978521429)
NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)
7DAF7E766C91C4681BD9E35A65ED1244CD021FD7E551BF6AB85D6DF31D7EAC10

Note Ratings

rated at rated by
2022-12-13 13:27:20 -0600 08956573BB2DC88E23E98EE7F3B4E96E8DD83B6A4D0EBCA73CA0D23CA67550C1 Rating Details
2022-12-13 13:50:23 -0600 099ED6B3483CCAAFF82E7DA324A5C9EBDE27115DEB1D8CF231520F8050170078 Rating Details
2022-12-13 20:21:31 -0600 0E3F6EB4AAF7233033251BACE0F0325D12DBDA5E1D67354D15807134017D9D96 Rating Details
2022-12-13 15:10:05 -0600 1072263077B70D8A33D125AAADF2A154557A9052308C4E6E527D9D17CDEF5F25 Rating Details
2022-12-13 11:46:37 -0600 1876C4C34E02274BC013B4C952618785674EA6A79DCAD1258AFC2751359E919E Rating Details
2022-12-13 20:11:52 -0600 2D4C83A96BA3B1DE6B629ABC08A9535751418C9761E70F4356D07687F99ABC1A Rating Details
2022-12-13 15:35:53 -0600 2DE4D1187BBD010232C9C95CF1EEE489DF83CAD1437EFF19EEEE62CF253E4D04 Rating Details
2022-12-13 19:04:33 -0600 2F5762DAD61B7FE245D64596F13CFB45FC1CF13004CDD4D28566E82B9EAC7354 Rating Details
2022-12-13 15:56:43 -0600 30B81CBCC14B55B4F31F55D77534B86E50EDE09EB06DC23EF7F8E69D61F4C8F9 Rating Details
2022-12-13 11:31:44 -0600 359A1C0F15FD54F6DD37B32E66B27769402C4C3CBB2D5D348D4EB13689EC6D5D Rating Details
2022-12-13 14:11:58 -0600 464F514091F013106E190C712492FDDD7A2F35D38B0E762F31374CC21B9FD858 Rating Details
2022-12-13 13:23:38 -0600 570A7FD8B3BD968E3FAC5E5F85509AFCF802B8C7C769921A0E9A3F8086C800FF Rating Details
2022-12-13 14:26:19 -0600 5EDC2B8BBEA2C25FBA40E8849AF6DD751A4AE52F674E4E2311C09F82909AD4F8 Rating Details
2022-12-13 16:16:30 -0600 5FB9B68061EDA5E93528C6A547111421B76EBB9BCE4A9F6DF39B3E468E23455C Rating Details
2022-12-14 23:37:48 -0600 74FE5BD176B7E87747776B5997199F538C24A2466DD8E11FBA894F1D5DA66DCC Rating Details
2022-12-13 13:45:06 -0600 826BAE2151D204EBF3C24D63FE2658259725887D0734C98510B6EE2CE5172C02 Rating Details
2022-12-13 18:52:21 -0600 8413633E576A4D72316DCBCC16DD6B9362C24EB27398FCD7DBA90B344D27F010 Rating Details
2022-12-13 14:15:06 -0600 9736DF42171A999208E640D9616E3AF1D2219C9694E38F806D374F891F58485E Rating Details
2022-12-13 12:44:50 -0600 9B927DB85E3A847E9DF9F137E5D3CA3637E8DBA7FEB2AF6A74703D4B4BD313ED Rating Details
2022-12-13 15:44:06 -0600 A1810ED3E455FCD80A3E8386936936A3E2C10B957F08EB490632A28C78C37FFB Rating Details
2022-12-13 11:48:30 -0600 A6706C9E1EE61DDA58847C2ACBE535C663BA583C6BB50C9326A09022B090B683 Rating Details
2022-12-13 17:24:15 -0600 A85F927C9E2230CA97A16F2D42A0863AE8F865C26076FFD7493E49F75D5CC756 Rating Details
2022-12-13 14:31:36 -0600 ADD6D84E1F57E6163E655F2B417E4696E606ADB54DD1EDE679CED0D4F3222ABD Rating Details
2022-12-13 12:15:04 -0600 E1EED97D6D2D5838BB61E20A0F4D02F98CE77030C7AA7F72AA66ACFB13C1A46D Rating Details
2022-12-13 16:03:23 -0600 E343F092F0B44A6E8DEC7F3A16DFE90A5DA9F420CB1B9EDE2292D0B45E00C827 Rating Details
2022-12-14 08:40:21 -0600 ECBA39C6F7FFF58DC3FAA41AE0F1FAD433AF9AC64A43D7BFBA9234CD1BF2B66C Rating Details
2022-12-14 01:04:08 -0600 ED631A047550482645D6AF42E75C31CF2FE81AC9C6220396E1657D510F2C2F7C Rating Details
2022-12-13 15:55:30 -0600 Rating Details
2022-12-13 16:40:48 -0600 Rating Details
2022-12-13 19:15:27 -0600 Rating Details
2022-12-13 18:53:58 -0600 Rating Details
2022-12-14 08:43:44 -0600 Rating Details
2022-12-13 11:48:30 -0600 Rating Details
2022-12-13 20:11:52 -0600 Rating Details
2022-12-14 01:04:08 -0600 Rating Details
2022-12-13 16:16:30 -0600 Rating Details
2022-12-14 23:37:48 -0600 Rating Details
2022-12-13 14:15:06 -0600 Rating Details
2022-12-13 12:44:50 -0600 Rating Details
2022-12-13 18:52:21 -0600 Rating Details
2022-12-13 15:44:06 -0600 Rating Details
2022-12-13 17:24:15 -0600 Rating Details
2022-12-13 15:55:30 -0600 Rating Details
2022-12-13 16:03:23 -0600 Rating Details
2022-12-13 11:31:44 -0600 Rating Details
2022-12-13 13:45:06 -0600 Rating Details
2022-12-13 14:31:36 -0600 Rating Details
2022-12-13 13:27:20 -0600 Rating Details
2022-12-13 11:46:37 -0600 Rating Details
2022-12-13 16:40:48 -0600 Rating Details
2022-12-13 20:21:31 -0600 Rating Details
2022-12-13 14:11:58 -0600 Rating Details
2022-12-13 12:15:04 -0600 Rating Details
2022-12-13 13:50:23 -0600 Rating Details
2022-12-13 13:23:38 -0600 Rating Details
2022-12-13 19:15:27 -0600 Rating Details
2022-12-13 15:35:53 -0600 Rating Details
2022-12-13 18:53:58 -0600 Rating Details
2022-12-13 14:26:19 -0600 Rating Details
2022-12-13 15:56:43 -0600 Rating Details
2022-12-13 15:10:05 -0600 Rating Details
2022-12-14 08:43:44 -0600 Rating Details
2022-12-13 19:04:33 -0600 Rating Details
2022-12-14 08:40:21 -0600 Rating Details